Nouvelle déclaration d'incident
No de la demande: 2011-0835
Numéro de référence du titulaire d'homologation: PROSAR Case #1-24485979
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-83
Nom du produit: UltraGuard Flea Tick Collar for Cats
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-504-2596
Nom du produit: UltraGuard Plus Drops for Cats
Liquide
Autre (préciser)
collarOui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Cat / Chat
domestic shorthair
1
Homme
7
8
lbs
Cutanée
Unknown / Inconnu
>24 hrs <=3 days / >24 h <=3 jours
Système
Persisted until death
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-24485979- The reporter, a pet owner, indicates his animal has been exposed to two insecticidal products produced by the registrant. The first, a flea and tick collar for cats contained the active ingredient tetrachlorvinphos. The second, a topical insecticidal drop for cats contained the active ingredients etofenprox and methoprene. The pet owner reported he applied the topical drop to his seven year eight pound male domestic shorthair cat four days prior to his initial contact with the registrant. He reported he applied the collar later the same day. The caller indicated he used the same two products last year with no trouble. The pet owner indicated the day following application the animal was not acting normal but did not clarify the signs seen. He reported he removed the collar and bathed the animal. The pet owner indicates the day prior to his initial contact with the registrant that the animal became paralyzed unable to walk. The animal was refusing food and water and had a seizure which lasted as long as 30 seconds. The pet owner was advised the signs seen would be unexpected following use of these products according to the label instructions. He was advised of proper decontamination and to seek prompt veterinary assistance. On routine follow up the pet owner indicated the animal was brought to the veterinarian 9:30am the day of the initial contact with the registrant. The animal was described as comatose. The veterinarian provided unspecified treatments but the animal developed cardiac arrest and died by 7pm that day. The caller was advised the signs seen were inconsistent with the toxicity profile of the active ingredients. He was advised of registrant supported necropsy to assist in determining cause of death. No further information is available.
Mort